Company profile: Medical Prognosis Institute
1.1 - Company Overview
Company description
- Provider of drug targeting, pharmaco Dx, and DNA microarray services for research projects in Denmark, supporting drug development, individual cancer prognostication and drug sensitivity prediction, and gene/drug discovery.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medical Prognosis Institute
Novacyt
HQ: France
Website
- Description: Provider of in vitro and molecular diagnostic tests and cellular diagnostics, with a growing portfolio in cancer and infectious disease, offering diagnostics product development, commercialisation, and contract design and manufacturing via Primerdesign and Lab21 Products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novacyt company profile →
BioImagene
HQ: United States
Website
- Description: Provider of digital pathology solutions for clinical diagnostics and drug discovery, delivering integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories, including IHC algorithms such as HER2, ER/PR, and p53.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioImagene company profile →
BerGenBio
HQ: Norway
Website
- Description: Provider of clinical-stage oncology therapeutics focused on first-in-class selective AXL kinase inhibitors for aggressive cancers, including bemcentinib (BGB324), a selective AXL inhibitor in clinical development for STK11 mutated NSCLC and severe respiratory infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BerGenBio company profile →
Advanced Accelerator Applications
HQ: France
Website
- Description: Provider of targeted radioligand therapies and precision imaging radioligands, offering LUTATHERA: a radioligand therapy using lutetium Lu 177 dotatate for treating tumors; PLUVICTO: a therapeutic radioligand containing lutetium Lu 177 vipivotide tetraxetan; diagnostic PET imaging kits NETSPOT, LOCAMETZ, and SOMAKIT TOC; and LysaKare to reduce renal radiation exposure during peptide-receptor radionuclide therapy with LUTATHERA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Accelerator Applications company profile →
Stemcentrx
HQ: United States
Website
- Description: Provider of disease-specific cancer therapies that target tumors at their roots to cure and significantly improve survival for patients, offering pharmaceutical services. Operates as a subsidiary of AbbVie.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stemcentrx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medical Prognosis Institute
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medical Prognosis Institute
2.2 - Growth funds investing in similar companies to Medical Prognosis Institute
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medical Prognosis Institute
4.2 - Public trading comparable groups for Medical Prognosis Institute
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →